Rchr
J-GLOBAL ID:201801009489277927   Update date: Nov. 07, 2024

Yusuke Suzuki

スズキ ユウスケ | Yusuke Suzuki
Affiliation and department:
Research field  (1): Nephrology
Research theme for competitive and other funds  (23):
  • 2022 - 2025 IgA腎症モデルマウスにおけるエンドセリン受容体拮抗薬による腎保護作用の解析
  • 2022 - 2025 IgA腎症の病因における粘膜免疫異常の主座の同定
  • 2022 - 2025 IgA腎症の進展機序におけるB細胞受容体シグナル伝達と異常IgA1産生制御の検証
  • 2021 - 2025 末期腎不全患者の突然死のリスク層別指標の開発と運動・栄養療法の併用効果の検証
  • 2021 - 2024 IgA腎症のMHC classIIの遺伝子多型による発症機序の解明
Show all
Papers (604):
  • Masahiro Muto, Hitoshi Suzuki, Yusuke Suzuki. New Insights and Future Perspectives of APRIL in IgA Nephropathy. International Journal of Molecular Sciences. 2024. 25. 19. 10340-10340
  • Hajime Nagasawa, Seiji Ueda, Hitoshi Suzuki, Celia Jenkinson, Yusuke Fukao, Maiko Nakayama, Tomoyuki Otsuka, Teruyuki Okuma, Wilmelenne Clapper, Kai Liu, et al. Sparsentan is superior to losartan in the gddY mouse model of IgA nephropathy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2024. 39. 9. 1494-1503
  • Marenao Tanaka, Tomohito Gohda, Nozomu Kamei, Maki Murakoshi, Tatsuya Sato, Mitsunobu Kubota, Michiyoshi Sanuki, Erika Ishiwata, Keisuke Endo, Yusuke Suzuki, et al. Associations between circulating levels of FABP4 and TNF receptors are more evident in patients with type 2 diabetes mellitus than in patients with type 1 diabetes mellitus. Endocrine connections. 2024
  • Ryousuke Aoki, Yoshihito Nihei, Keiichi Matsuzaki, Hitoshi Suzuki, Masao Kihara, Asa Ogawa, Tomoya Nishino, Satoru Sanada, Shinya Yokote, Masahiro Okabe, et al. Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan. Kidney360. 2024
  • Masayuki Maiguma, Masao Kihara, Maki Hamaguchi, Takashi Kobayashi, Koshi Yamada, Miyuki Takagi, Harumi Saeki, Tomohito Gohda, Yusuke Suzuki. Successful treatment of acute tubulointerstitial nephritis probably due to Benikoji CholesteHelp®, a supplement containing red yeast rice. CEN case reports. 2024
more...
MISC (291):
  • 梅澤由佳子, 鈴木仁, 廣瀬瞳, 齋藤翠, 岩崎雅子, 福田裕光, 高原久嗣, 冨田茂樹, 鈴木祐介. COVID-19ワクチン接種後に診断された腎疾患31症例の検討. 日本腎臓学会誌(Web). 2023. 65. 3
  • 小笠智美, 鈴木仁, 梅澤由佳子, 濱口真希, 越田剛生, 福田裕光, 高原久嗣, 鈴木祐介. 腎機能によるアンジオテンシン受容体ネプリライシン阻害薬の有用性の違い. 日本腎臓学会誌(Web). 2023. 65. 3
  • 加藤有紗, 鈴木仁, 越田剛生, 小笠智美, 濱口真希, 福田裕光, 高原久嗣, 鈴木祐介. 腎機能低下症例における高中性脂肪血症治療. 日本腎臓学会誌(Web). 2023. 65. 3
  • 安部憲一郎, 鈴木仁, 越田剛生, 加藤有紗, 小笠智美, 梶尾優希, 福田裕光, 高原久嗣, 冨田茂樹, 鈴木祐介. 臨床所見を認めないFabry病患者に対し腎組織所見をもとに治療介入した一例. 日本腎臓学会誌(Web). 2023. 65. 6-E
  • 冨田茂樹, 佐伯春美, 橋爪茜, 加藤有紗, 越田剛生, 福田裕光, 高原久嗣, 鈴木仁, 鈴木祐介. Central fibrous areas(CFAs)と考えた病変を有した糖尿病歴が比較的短期間な糖尿病性腎症の一例. 日本腎臓学会誌(Web). 2023. 65. 6-E
more...
Lectures and oral presentations  (159):
  • Clinical application of IgA type autoantibodies against mesangial autoantigen, βII-spectrin, in IgA nephropathy
    (American Society of Nephrology (ASN2023) 2023)
  • Investigation of T Cells contributing to the production of IgA-Type autoantibodies against mesangial Cells in IgA nephropathy
    (American Society of Nephrology (ASN2023) 2023)
  • Understanding the role of APRIL in the pathogenesis of IgAN
    (the 17th international Symposium on IgA Nephropathy (IIGANN 2023) 2023)
  • B cell targeting therapy
    (the 17th international Symposium on IgA Nephropathy (IIGANN 2023) 2023)
  • The mechanism for cell-surface expression of beta2-spectrin at mesangial region
    (the 17th international Symposium on IgA Nephropathy (IIGANN 2023) 2023)
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page